JOHN C. HODGMAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Sarepta Therapeutics, Inc.

Filing Date Source Excerpt
2010-05-04 Mr. Hodgman's significant executive-level experience as a finance executive with biotechnology and biopharmaceutical companies qualifies him for service as a member of the Board of Directors.

Data sourced from SEC filings. Last updated: 2025-08-30